Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Shunji Watanabe"'
Autor:
Oyunjargal Bat-Erdene, Kouichi Miura, Hiroshi Maeda, Shunji Watanabe, Mamiko Tsukui, Yoshinari Takaoka, Hiroaki Nomoto, Rie Goka, Naoki Morimoto, Hironori Yamamoto
Publikováno v:
Gastrointestinal Disorders, Vol 5, Iss 1, Pp 15-27 (2023)
Background: Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is recommended for patients with chronic liver diseases as the vaccine can prevent and/or reduce the severity of SARS-CoV-2 infection. However, we have littl
Externí odkaz:
https://doaj.org/article/c5c8004121764c58b221ef76d8a0d1d2
Autor:
Kazufumi Kobayashi, Sadahisa Ogasawara, Aya Takahashi, Yuya Seko, Hidemi Unozawa, Rui Sato, Shunji Watanabe, Michihisa Moriguchi, Naoki Morimoto, Satoshi Tsuchiya, Kenji Iwai, Masanori Inoue, Keita Ogawa, Takamasa Ishino, Terunao Iwanaga, Takafumi Sakuma, Naoto Fujita, Hiroaki Kanzaki, Keisuke Koroki, Masato Nakamura, Naoya Kanogawa, Soichiro Kiyono, Takayuki Kondo, Tomoko Saito, Ryo Nakagawa, Eiichiro Suzuki, Yoshihiko Ooka, Shingo Nakamoto, Akinobu Tawada, Tetsuhiro Chiba, Makoto Arai, Tatsuo Kanda, Hitoshi Maruyama, Kengo Nagashima, Jun Kato, Norio Isoda, Takeshi Aramaki, Yoshito Itoh, Naoya Kato
Publikováno v:
Liver Cancer, Pp 1-13 (2021)
Background and Aims: The prognosis of patients with advanced hepatocellular carcinoma (HCC) is expected to improve as multiple molecular target agents (MTAs) are now available. However, the impact of the availability of sequential MTAs has not been f
Externí odkaz:
https://doaj.org/article/3d27bd60476f43d0ad39fa2137391db5
Autor:
Hiroaki Nomoto, Naoki Morimoto, Kouichi Miura, Shunji Watanabe, Yoshinari Takaoka, Hiroshi Maeda, Takahiro Sasaki, Yohei Koyashiki, Hidekazu Kurata, Norikatsu Numao, Norio Isoda, Hironori Yamamoto
Publikováno v:
BMC Gastroenterology, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Chronic liver disease (CLD) is often complicated by severe thrombocytopenia (platelet count 50,000/µL at baseline: the proportions of patients who did not require platelet transfusion were 84–96%, which might be overestimated.
Externí odkaz:
https://doaj.org/article/2de53fe02bed4e8e960a0779c21ce522
Autor:
Hiroshi Maeda, Kouichi Miura, Naoki Morimoto, Shunji Watanabe, Mamiko Tsukui, Yoshinari Takaoka, Hiroaki Nomoto, Rie Goka, Naoto Sato, Kazue Morishima, Yasunaru Sakuma, Naohiro Sata, Noriyoshi Fukushima, Norio Isoda, Hironori Yamamoto
Publikováno v:
Cancers, Vol 14, Iss 3, p 752 (2022)
Background: Conventional therapies, including chemoembolization and radiation therapy, have been expected to prolong the prognosis of hepatocellular carcinoma (HCC) patients with extrahepatic metastases, which remains poor. However, little informatio
Externí odkaz:
https://doaj.org/article/c3ebb082225a4d0c9d7cab21c9d3e732
Autor:
Kouichi Miura, Naoshi Arai, Rie Goka, Naoki Morimoto, Shunji Watanabe, Norio Isoda, Hironori Yamamoto, Kazuhiko Kotani
Publikováno v:
Antioxidants, Vol 10, Iss 2, p 239 (2021)
Patients with nonalcoholic fatty liver disease (NAFLD) show dyslipidemia and a high risk for coronary heart disease (CHD). However, conventional atherosclerotic lipids are found at low levels in NAFLD patients with advanced fibrosis, in whom the risk
Externí odkaz:
https://doaj.org/article/507b3153e3734e54a28b9911afbb92a5
Autor:
Oyunjargal, Baterdene, Kouichi, Miura, Wataru, Ueno, Shunji, Watanabe, Mamiko, Tsukui, Hiroaki, Nomoto, Rie, Goka, Hiroshi, Maeda, Hironori, Yamamoto, Naoki, Morimoto
Publikováno v:
Clinical Journal of Gastroenterology. 15:1101-1107
A fraction of patients with hepatocellular carcinoma (HCC) shows unexpected rapid tumor growth, called hyperprogressive disease (HPD) after the initiation of atezolizumab and bevacizumab (ATZ + BEV). However, little information is available concernin
Autor:
Kouichi, Miura, Hiroshi, Maeda, Naoki, Morimoto, Shunji, Watanabe, Mamiko, Tsukui, Yoshinari, Takaoka, Hiroaki, Nomoto, Rie, Goka, Kazuhiko, Kotani, Hironori, Yamamoto
Publikováno v:
World Journal of Gastrointestinal Pathophysiology. 13:96-106
Vibration-controlled transient elastography (VCTE) is proposed as a second step of examination to assess liver fibrosis in patients with nonalcoholic fatty liver disease (NAFLD) after triaging by the fibrosis-4 (FIB-4) index. Recently, VCTE-based sco
Autor:
Kaori Kuramitsu, Tomomi Kogiso, Reiko Itoh, Atsushi Takai, Yoko Yoshimaru, Masatoshi Ishigami, Po-Sung Chu, Akinobu Takaki, Shohei Narita, Shunji Watanabe, Keisuke Kakisaka, Tomoharu Yamada, Kazuki Maesaka, Koji Ogawa, Hiroto Egawa
Publikováno v:
Kanzo. 62:785-792
Autor:
Rui Sato, Michihisa Moriguchi, Kenji Iwai, Satoshi Tsuchiya, Yuya Seko, Aya Takahashi, Kazufumi Kobayashi, Sadahisa Ogasawara, Shunji Watanabe, Naoki Morimoto, Naoya Kato, Yoshito Itoh, Takeshi Aramaki
Publikováno v:
Hepatology research : the official journal of the Japan Society of HepatologyREFERENCES. 52(10)
There is insufficient evidence regarding the safety and efficacy of molecular targeted agents (MTAs) for elderly patients with hepatocellular carcinoma (HCC), who are likely to be vulnerable to adverse events (AEs) of therapy. The aim of this study w
Autor:
Hirotaka Arai, Atsushi Naganuma, Takeshi Nihei, Tadashi Ikegami, Hidekazu Kurata, Takaaki Ohtake, Toshiyuki Tahara, Kouichi Miura, Katsuhiko Horiuchi, Ken Sato, Satoru Kakizaki, Shigeo Tano, Toshiro Kamoshida, Norio Isoda, Yukimura Fukaya, Atsuko Soeda, Makoto Iijima, Toshiya Ohtake, Takeharu Asano, Takeshi Hatanaka, Masashi Namikawa, Takeshi Fujieda, Naoki Morimoto, Shunji Watanabe, Takashi Ueno, Takashi Kosone, Toshimitsu Murohisa, Hironori Yamamoto, Yoshinari Takaoka
Publikováno v:
Hepatology Research. 51:51-61
AIM This study aimed to evaluate the real-world efficacy and safety of 12-week sofosbuvir/velpatasvir (SOF/VEL) treatment for patients with decompensated liver cirrhosis caused by hepatitis C virus (HCV) infection. METHODS A total 72 of patients with